Skip to content

Local Wound Infiltration for Tracheal Reconstruction

Local Wound Infiltration Versus Bilateral Superficial Cervical Plexus Block With Levobupivacaine for Upper Tracheal Resection and Reconstruction Surgery Under General Anesthesia.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02949661
Enrollment
0
Registered
2016-10-31
Start date
2016-09-30
Completion date
2017-05-31
Last updated
2020-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Tracheal Resection, Tracheal Reconstruction Surgery

Brief summary

Tracheal resection and reconstruction (TRR) is the treatment of choice for most patients with tracheal stenosis or tracheal tumors .The postintubation tracheal stenosis is the common indication for (TRR).The immediate postoperative period can be anxiety provoking for some reasons such as requirement to maintain a flexed neck, oxygen mask, and surgical pain which inadequately treated. Bilateral superficial cervical plexus block (BSCPB) is a popular regional anesthesia technique for its feasibility and efficacy. The use of regional anesthesia in combination with general anesthesia may lighten the level of general anesthesia required , provide prolonged postoperative analgesia and reduce the requirements for opioid analgesics Local anesthetic infiltration into the surgical incision can relieve pain at the wound site after surgery, as part of multimodal analgesic approach. Levobupivacaine, is S-enantiomer of bupivacaine, has strongly emerged as a safer alternative for regional anesthesia than bupivacaine . Levobupivacaine has been found to be equally efficacious as bupivacaine, but with a superior pharmacokinetic profile. Clinically, levobupivacaine has been observed to be well tolerated in regional anesthesia techniques both after bolus administration and continuous post-operative infusion.

Detailed description

The aim of this study is to evaluate the intra- and postoperative efficacy of local wound infiltration versus bilateral superficial cervical plexus block with levobupivacaine for upper tracheal resection and reconstruction surgery.

Interventions

Patients will receive bilateral superficial cervical plexus block

Patients will receive local wound infiltration

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists physical class status I or II * Undergoing elective upper tracheal resection and reconstruction surgery

Exclusion criteria

* Age less than18 years * Patients with preoperative medication included opioid * History of allergy to the drugs used * Coagulation disorders * Pregnancy * Patient refusal * Local sepsis * Inability to understand the study protocol or pain scale.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain scoreFor 24 hours after surgeryPostoperative pain scores will be assessed using postoperative visual analogue score

Secondary

MeasureTime frameDescription
Bispectral indexFor 4 hours after start of surgery
Systolic blood pressureFor 4 hours after start of surgery
Diastolic blood pressureFor 4 hours after start of surgery
Heart rateFor 4 hours after start of surgery
End-tidal Carbon dioxide tensionFor 4 hours after start of surgery
Duration of analgesiaFor 24 hours after surgeryIt is defined as time taken for first analgesic request of analgesia from extubation
Cumulative analgesic consumptionFor 24 hours after surgerytotal analgesics used for 24 hrs after surgery
Cortisol serumbefore induction ,one hour after start of surgery and one hour after end of surgeryPlasma cortisol assay
Peripheral oxygen saturationFor 4 hours after start of surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026